MX2017012259A - Ensayos mejorados para la potencia de células epiteliales pigmentarias de retina humana (rpe) y progenitores de fotorreceptores. - Google Patents

Ensayos mejorados para la potencia de células epiteliales pigmentarias de retina humana (rpe) y progenitores de fotorreceptores.

Info

Publication number
MX2017012259A
MX2017012259A MX2017012259A MX2017012259A MX2017012259A MX 2017012259 A MX2017012259 A MX 2017012259A MX 2017012259 A MX2017012259 A MX 2017012259A MX 2017012259 A MX2017012259 A MX 2017012259A MX 2017012259 A MX2017012259 A MX 2017012259A
Authority
MX
Mexico
Prior art keywords
rpe
cells
potency
retinal pigment
pigment epithelium
Prior art date
Application number
MX2017012259A
Other languages
English (en)
Inventor
V Klimanskaya Irina
Kathryn Carson Julie
Gay Roger
Gikova Ivanova Yordanka
Original Assignee
Astellas Inst For Regenerative Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Inst For Regenerative Medicine filed Critical Astellas Inst For Regenerative Medicine
Publication of MX2017012259A publication Critical patent/MX2017012259A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/164—Retinal disorders, e.g. retinopathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta descripción proporciona un nuevo ensayo de fagocitosis para probar la función de células del RPE y progenitores de fotorreceptor usando una etiqueta fluorescente sensible al pH.
MX2017012259A 2015-03-23 2016-03-23 Ensayos mejorados para la potencia de células epiteliales pigmentarias de retina humana (rpe) y progenitores de fotorreceptores. MX2017012259A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562136660P 2015-03-23 2015-03-23
PCT/US2016/023839 WO2016154357A1 (en) 2015-03-23 2016-03-23 Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors

Publications (1)

Publication Number Publication Date
MX2017012259A true MX2017012259A (es) 2018-05-17

Family

ID=55752717

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017012259A MX2017012259A (es) 2015-03-23 2016-03-23 Ensayos mejorados para la potencia de células epiteliales pigmentarias de retina humana (rpe) y progenitores de fotorreceptores.
MX2022010736A MX2022010736A (es) 2015-03-23 2017-09-25 Ensayos mejorados para la potencia de celulas epiteliales pigmentarias de retina humana (rpe) y progenitores de fotorreceptores.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022010736A MX2022010736A (es) 2015-03-23 2017-09-25 Ensayos mejorados para la potencia de celulas epiteliales pigmentarias de retina humana (rpe) y progenitores de fotorreceptores.

Country Status (16)

Country Link
US (3) US11422125B2 (es)
EP (3) EP3869195B1 (es)
JP (3) JP6902474B2 (es)
KR (2) KR102577776B1 (es)
CN (2) CN107889507B (es)
AU (2) AU2016235176B2 (es)
CA (2) CA3188112A1 (es)
DK (1) DK3274710T3 (es)
ES (1) ES2877400T3 (es)
HU (1) HUE054946T2 (es)
IL (3) IL303401A (es)
MX (2) MX2017012259A (es)
PL (1) PL3274710T3 (es)
PT (1) PT3274710T (es)
SG (3) SG11201707775TA (es)
WO (1) WO2016154357A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE054517T2 (hu) 2010-07-23 2021-09-28 Astellas Inst For Regenerative Medicine Eljárások sejtek ritka alpopulációinak detektálására és nagymértékben tisztított sejtkészítmények
CN107889507B (zh) 2015-03-23 2021-11-26 安斯泰来再生医药协会 改进的人视网膜色素(rpe)细胞和感光祖细胞的效能测定
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations
IL292610A (en) 2019-10-30 2022-07-01 Astellas Inst For Regenerative Medicine Methods for the production of retinal pigment epithelial cells
DE102022103893A1 (de) * 2022-02-18 2023-08-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Membranvesikel, die einen spektroskopisch nachweisbaren Indikator beinhalten, und deren Verwendung in einem Verfahren zum Nachweis der Phagozytose-Funktion bei biologischen Zellen

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432711B1 (en) 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
US20110171185A1 (en) 1999-06-30 2011-07-14 Klimanskaya Irina V Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
IL147179A0 (en) 1999-06-30 2002-08-14 Advanced Cell Tech Inc Cytoplasmic transfer to de-differentiate recipient cells
US20040199935A1 (en) 1999-06-30 2004-10-07 Chapman Karen B. Cytoplasmic transfer to de-differentiate recipient cells
US20040180430A1 (en) 1999-09-07 2004-09-16 West Michael D. Methods of restoring telomere length and extending cell lifespan using nuclear transfer
US20050255596A1 (en) 1999-09-07 2005-11-17 West Michael D Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer
CA2383790C (en) 1999-09-07 2016-11-22 Advanced Cell Technology, Inc. Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
CN1387401A (zh) 1999-11-02 2002-12-25 马萨诸塞大学 单倍体基因组用于遗传诊断、修饰和增殖
MXPA02006093A (es) 1999-12-20 2004-08-23 Univ Massachusetts Celulas tipo madre o embrionicas producidas por transplante nuclear de especies de cruza.
CA2394812A1 (en) 1999-12-20 2001-06-28 Anthony C.F. Perry A method to produce cloned embryos and adults from cultured cells
AU2002258477A1 (en) 2001-03-08 2002-09-24 Advanced Cell Technology, Inc. Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
WO2002073188A1 (en) 2001-03-13 2002-09-19 Advanced Cell Technology, Inc. Method for generating replacement cells and/or tissues
EP1444326A4 (en) 2001-08-24 2006-06-28 Advanced Cell Tech Inc SCREENING ASSAYS FOR IDENTIFICATION OF AGENTS INDUCING DIFFERENTIATION, AND PRODUCTION OF CELLS DIFFERENTIATED FOR CELL THERAPY
AU2003300111A1 (en) 2002-12-27 2004-07-29 Advanced Cell Technology, Inc. Sperm-induced cellular activation
US20060112438A1 (en) 2004-01-02 2006-05-25 West Michael D Novel culture systems for ex vivo development
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
US20190282622A1 (en) 2004-01-23 2019-09-19 Astellas Institute For Regenerative Medicine Modalities for the treatment of degenerative diseases of the retina
JP2007522131A (ja) 2004-01-23 2007-08-09 アドバンスド セル テクノロジー、インコーポレイテッド 網膜変性疾患治療のための改良された様式
GB0407836D0 (en) 2004-04-06 2004-05-12 Univ Cambridge Tech Fluorescent dyes and complexes
EP2479256A1 (en) 2004-11-04 2012-07-25 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
US7893315B2 (en) 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
US20060263338A1 (en) 2005-03-04 2006-11-23 Jacoby Douglas B Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
US8889122B2 (en) 2005-05-09 2014-11-18 Mytogen, Inc. Cellular cardiomyoplasty as supportive therapy in patients with heart disease
EP1984487B1 (en) 2005-08-03 2022-10-12 Astellas Institute for Regenerative Medicine Improved methods of reprogramming animal somatic cells
US20090271335A1 (en) 2005-10-20 2009-10-29 Advanced Cell Technology, Inc. Totipotent, Nearly Totipotent or Pluripotent Mammalian Cells Homozygous or Hemizygous for One or More Histocompatibility Antigent Genes
KR20150142061A (ko) 2006-05-03 2015-12-21 오카타 세라퓨틱스, 인크. 배아 줄기 세포 및 배-유도 세포의 유도
EP3190178A1 (en) 2007-02-23 2017-07-12 Astellas Institute for Regenerative Medicine Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
WO2009051671A1 (en) 2007-10-12 2009-04-23 Advanced Cell Technology, Inc. Improved methods of producing rpe cells and compositions of rpe cells
US20110028780A1 (en) 2007-12-19 2011-02-03 Robert Lanza Methods Of Producing Pluripotent Stem Cell-Generated Embryos, And Animals Derived Therefrom
WO2011063005A2 (en) 2009-11-17 2011-05-26 Advanced Cell Technology, Inc. Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
HUE054517T2 (hu) 2010-07-23 2021-09-28 Astellas Inst For Regenerative Medicine Eljárások sejtek ritka alpopulációinak detektálására és nagymértékben tisztított sejtkészítmények
US20120184035A1 (en) 2011-01-13 2012-07-19 Sadhana Agarwal Methods and Compositions For Reprogramming Cells
AU2012340020A1 (en) 2011-11-14 2014-07-03 Astellas Institute For Regenerative Medicine Pharmaceutical preparations of human RPE cells and uses thereof
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
DK2785359T3 (en) 2011-11-30 2018-10-29 Astellas Inst For Regenerative Medicine MESENKYMAL STROMACELLES AND APPLICATIONS RELATED
PT2788472T (pt) 2011-12-06 2019-04-01 Astellas Inst For Regenerative Medicine Método de diferenciação dirigida para a produção de células endoteliais corneanas
US9511152B2 (en) 2012-04-05 2016-12-06 The Board Of Regents Of The University Of Texas System Multicolored pH-activatable fluorescence nanoplatform
ES2896354T3 (es) 2012-12-21 2022-02-24 Astellas Inst For Regenerative Medicine Métodos para la producción de plaquetas a partir de células madre pluripotentes
US20160175362A1 (en) 2014-03-14 2016-06-23 Ocata Therapeutics, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
PT2970903T (pt) 2013-03-15 2024-02-26 Astellas Inst For Regenerative Medicine Fotorrecetores e progenitores de fotorrecetores produzidos a partir de células estaminais pluripotentes
US20160175361A1 (en) 2014-03-14 2016-06-23 Advanced Cell Technology, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
US11241460B2 (en) 2013-03-15 2022-02-08 Astellas Institute For Regenerative Medicine Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
AU2015311702A1 (en) 2014-09-05 2017-04-06 Astellas Institute For Regenerative Medicine Retinal ganglion cells and progenitors thereof
CN107889507B (zh) 2015-03-23 2021-11-26 安斯泰来再生医药协会 改进的人视网膜色素(rpe)细胞和感光祖细胞的效能测定
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations

Also Published As

Publication number Publication date
EP3869195B1 (en) 2024-03-20
EP4343331A2 (en) 2024-03-27
IL293110A (en) 2022-07-01
JP7386206B2 (ja) 2023-11-24
IL293110B1 (en) 2023-07-01
JP6902474B2 (ja) 2021-07-14
SG11201707775TA (en) 2017-10-30
AU2016235176A1 (en) 2017-10-26
EP3869195A1 (en) 2021-08-25
IL254617B (en) 2022-06-01
AU2022218516A1 (en) 2022-09-08
EP3274710A1 (en) 2018-01-31
ES2877400T3 (es) 2021-11-16
US11680941B2 (en) 2023-06-20
SG10201912315UA (en) 2020-02-27
JP2018516535A (ja) 2018-06-28
IL254617A0 (en) 2017-11-30
IL293110B2 (en) 2023-11-01
DK3274710T3 (da) 2021-09-06
CN113930476A (zh) 2022-01-14
CA2980580C (en) 2024-01-23
AU2016235176B2 (en) 2022-05-19
HUE054946T2 (hu) 2021-10-28
MX2022010736A (es) 2022-09-23
JP2021168655A (ja) 2021-10-28
WO2016154357A1 (en) 2016-09-29
CN107889507A (zh) 2018-04-06
SG10201907918VA (en) 2019-10-30
CA2980580A1 (en) 2016-09-29
PL3274710T3 (pl) 2021-12-27
KR102577776B1 (ko) 2023-09-11
CA3188112A1 (en) 2016-09-29
US20180052150A1 (en) 2018-02-22
US20230051804A1 (en) 2023-02-16
KR20180011761A (ko) 2018-02-02
PT3274710T (pt) 2021-07-06
CN107889507B (zh) 2021-11-26
KR20230132893A (ko) 2023-09-18
US20230408489A1 (en) 2023-12-21
EP3274710B1 (en) 2021-06-09
US11422125B2 (en) 2022-08-23
JP2024037720A (ja) 2024-03-19
IL303401A (en) 2023-08-01

Similar Documents

Publication Publication Date Title
MX2022010736A (es) Ensayos mejorados para la potencia de celulas epiteliales pigmentarias de retina humana (rpe) y progenitores de fotorreceptores.
TWD190312S (zh) 項鍊
TWD182272S (zh) 項鍊
TWD170354S (zh) 項鍊
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
TWD170595S (zh) 項鍊
TWD177948S (zh) 垂飾
MA39248B1 (fr) Anticorps anti-jagged1 et procédés d'utilisation correspondants
TWD193740S (zh) 戒指
TWD178832S (zh) 手鍊
TWD184636S (zh) 戒指
WO2018162740A3 (en) Cell culture supplements
BR112016029935A2 (pt) ?anticorpos anti-brdu, complexo, formulação farmacêutica e uso de anticorpo?
TWD190908S (zh) 瓶子(三)
TWD190909S (zh) 瓶子(三)衍生一
TWD159204S (zh) 眼內鏡片保持具之部分
TWD178007S (zh) 眼鏡(五)
TWD190076S (zh) bottle
TWD191961S (zh) 戒指
TWD188642S (zh) 指環
TWD201625S (zh) 眼鏡
TWD199330S (zh) 眼鏡
TWD201626S (zh) 眼鏡
TWD190911S (zh) 瓶子(二)衍生一
TWD193869S (zh) Safe